A scalable, low-burden behavioral intervention using ultra-brief, remotely delivered meditation was tested in a randomized controlled trial with multimodal outcome assessment under real-world conditions. The intervention aimed to address rising subclinical mental health symptoms, though the abstract does not report specific findings or effect sizes.
People with major depression who responded to either psilocybin or escitalopram showed distinct changes in brain network connectivity compared to non-responders. Responders had increased linear connectivity within the ventral attention network and greater nonlinear connectivity within the default mode and ventral attention networks. Psilocybin responders showed enhanced coordination between higher-order networks, while escitalopram responders showed reduced connectivity within networks linked to self-referential thought and salience processing. These patterns suggest the two antidepressants work through different mechanisms, with nonlinear connectivity analyses revealing effects not captured by traditional linear measures.